Brief: SMS Lifesciences India Gets EIR With VAI Status From USFDA
16/07/2025 08:55
July 16 (Reuters) - SMS Lifesciences India Ltd SMSL.NS: SMS LIFESCIENCES INDIA LTD - RECEIVES EIR WITH VAI STATUS FROM USFDA SMS LIFESCIENCES INDIA LTD - RECEIPT OF EIR ENABLES ACCESS TO US AND GLOBAL MARKETS Source text: ID:nBSE4Bdk10 Further company coverage: SMSL.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Haleos Labs
See all newsBrief: Haleos Labs Entered Into Strategic Development Collaboration With Hrv Global Life Sciences
SMS Lifesciences India soars; facility gets US FDA clearance
Brief: SMS Lifesciences India Gets EIR With VAI Status From USFDA
Brief: SMS Lifesciences India Dec-Quarter Consol Net Profit Rises
Brief: Sms Lifesciences India Sept-Qtr Consol Net Profit Falls